From the Results of Yesterday to the Biologic Drugs of Tomorrow
April 11, 2018|

A thousand small delays and opportunities for error can snowball over the years of a complex biotherapeutic drug development program. They add up to lost time and increased risk in an endeavor that has little tolerance for either. It doesn’t have to be this way.

Biosimilars Intensify the Need for Harmonized Data
February 28, 2018|

To get the most out of recent innovations in biopharma development and QC such as multi-attribute monitoring, it’s time to better connect the systems that manage biopharma data. This series explores the what, the why, and the how of better biopharma data.

Biopharma Data: Chaos or Harmony?
January 29, 2018|

If data can throw your biotherapeutic development program into chaos, it can also help move you forward. Let’s see how.